SERIES B·Nov 15, 2026, 10:12 AM ET·Emerging signal

Luminoah raises $25M to expand access to FDA-cleared enteral feeding system

TL;DR:

  • Luminoah secured $25 million in Series B funding with Sandbox Clinical Ventures leading the round.
  • Luminoah aims to broaden access to its FDA-cleared system for enteral feeding.
  • Blue Venture Fund, GV (Google Ventures) and Sands Capital joined the financing alongside other investors.

Summary

Luminoah secured a $25 million Series B led by Sandbox Clinical Ventures to broaden access to its enteral feeding system. The device already has FDA clearance. Participants include Blue Venture Fund, GV (Google Ventures), Sands Capital and existing backers, placing fresh capital behind the effort to reach more patients and care providers.

Open vabio.org in a new tab ↗
Powered by Moatly Lens

The Bigger Picture

The headline tells you what happened. Discover the facts behind it, the forces at work, the connections that matter, and what comes next.

Why This Matters

Luminoah just raised $25 million to help more patients get access to its FDA-cleared tube feeding technology.

What We Actually Know

  • Reported, not yet confirmedThe round included high-profile investors like GV (Google Ventures) and Blue Venture Fund.
Sources: vabio.org

How the Pieces Connect

  • InferenceReported, not yet confirmedHaving FDA clearance already in hand reduces the regulatory risk for these investors, focusing the capital on commercial growth instead of research.
Sources: vabio.org

What This Could Change

  • ScenarioThe involvement of Blue Venture Fund suggests a strong interest from insurance-linked investors in improving home-based care efficiency.
Sources: vabio.org

Where the Story Goes Next

  • How many patients are currently using the system, and what is the target for the next year?
Sources: vabio.org